Anthony Davis

Anthony Davis has over 19 years of experience in Quality Assurance and Quality Control. Anthony began their career in 2002 as a Quality Assurance Specialist II at Novo Nordisk Pharmaceuticals. In 2004, they moved to Amgen Inc. as a Quality Assurance Specialist I, where they were responsible for the design and implementation of various quality systems. In 2005, they joined MassBiologics as a Quality Assurance Systems Manager, where they were responsible for ensuring the implementation and management of systems with respect to written standard operating procedures. In 2008, they moved to ARIAD Pharmaceuticals, INC. as a Quality Professional, where they led global quality systems. In 2010, they joined Biogen Idec as a Manager, R&D Compliance, where they oversaw the design, planning and development aspects of the Research & Development quality systems. In 2015, they moved to Alexion Pharmaceuticals, Inc. as an AD, R&D Quality. Finally, in 2017, they joined Dicerna Pharmaceuticals, Inc. as Head Of Quality, a role they held until 2021, when they moved to Cullinan Oncology as Head Of Quality.

Anthony Davis completed an Executive Management Program at the Yale School of Management in 2020. In 1996, they attended the University of North Carolina at Chapel Hill School of Medicine. Anthony received a BS in Biology from the University of North Carolina Wilmington and an MS in Business Administration from the NEW YORK INSTITUTE OF TECHNOLOGY. Additionally, they obtained certifications from Barnett International, Langevin Learning Services, IASSC Certified Provider, and the Project Management Institute. These certifications include a Clinical Research Associate/Coordinator, Training Director, Six Sigma Green Belt, and Project Management Professional, respectively.